Drug Topics Hospital Pharmacists' Report

September 27, 2012

Web Version  |   Unsubscribe  |  Digital Edition  |  Share with a colleague

Facebook Like   Twitter Tweet

TOP STORY

Long-term use of NSAIDs after MI is risky

Researchers in one study advise caution in long-term use of NSAIDs for patients who have experienced a first-time myocardial infarction. » More

Continuing Education

New CPE Series: MTM in Patients with Diabetes

Welcome to a new CPE series: Medication Therapy Management (MTM) in Patients with Diabetes, which has been designed for pharmacists who take care of patients with diabetes. You can earn up to 14 CPE credits from September 2012-March 2013 with 7 monthly knowledge-based activities. This month, the professional development activity will cover the pathophysiology, diagnosis, screening, and risk factors associated with diabetes mellitus.

To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to login.

TODAY'S HEADLINES

ASHP adds new center for practice advancement

The American Society of Health-System Pharmacists' new Center on Pharmacy Practice Model Advancement will aid in its goal to place pharmacists in a more enhanced role as direct patient care providers. » More

Gabapentin may be effective chronic cough therapy

For patients with refractory chronic cough, gabapentin may be an effective treatment to help improve cough-specific quality of life, according to a study published in The Lancet. » More

Kidney stones increase risk of ESRD

A higher risk for end-stage renal disease or other adverse renal outcomes is associated with patients who have had at least one symptomatic kidney stone episode, according to study results published in BMJ. » More

Survey

Has your institution decided to be part of an accountable care organization?

1. Yes, we have established an ACO as of July 1, 2012.

2. Yes, we have applied for ACO status.

3. Yes, but we have not yet applied for ACO status.

4. No, we have no plans to apply for ACO status.


Respond here and see what your colleagues think too.

Want to see the results of our last survey about who your colleagues are voting for in the upcoming election? Click here.


 

Subscribe Now!

You must click here to continue receiving the Drug Topics Hospital Pharmacists' Report

Check these out, too

FDA approves aflibercept injection for ME

Early antibiotic use may increase IBD risk

FDA approves new indication for denosumab

Conviction in online counterfeit Rx case

Voices

Anticoagulation Update

JP at Large: Over the line

View from the Zoo: A pharmacy parable

Viewpoints: Guest columnists' commentary

Regulatory and Legal: News, features, analysis

Meetings and Events

 
Powered by Modern Medicine Advanstar Medical Communications Group